posted on 2022-07-22, 07:31authored byLea Wittmann, Anja C. Wachter, Hedda Schrey, Rainer Schobert
An analogue of the <i>Streptomyces</i> metabolite
JBIR-141,
featuring a delicate <i>N</i>-nitrosohydroxylamine, a 3-acyltetramic
acid, and an oxazoline, was synthesized by a convergent strategy from l-alanine, l-threonine, and l-glutamic acid.
Key steps were the cyclization of an Ala–Thr derivative to
give the oxazoline, a Dieckmann condensation affording the 3-acyltetramic
acid, and the <i>N</i>-nitrosation of a hydroxylamino derivative
of glutamic acid. An adequate protecting group strategy was established
for coupling the three building blocks.